• Molecular NameAjmaline
  • SynonymAjmalin
  • Weight326.44
  • Drugbank_IDDB01426
  • ACS_NO4360-12-7
  • Show 2D model
  • LogP (experiment)1.81
  • LogP (predicted, AB/LogP v2.0)1.59
  • pka8.2
  • LogD (pH=7, predicted)0.37
  • Solubility (experiment)Slightly soluble
  • LogS (predicted, ACD/Labs)(ph=7)-1.12
  • LogSw (predicted, AB/LogsW2.0)2.18
  • Sw (mg/ml) (predicted, ACD/Labs)2.28
  • No.of HBond Donors2
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds1
  • TPSA46.94
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA class Ia antiarrhythmic agent. It is often used to bring out typical findings of ST elevations in patients suspected of having Brugada syndrome.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmMainly metabolised by the liver.
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A